Insider Buys and Sells of Ariad Pharmaceuticals (ARIA)

19.57 (1y: +17%)

Market Cap	3.59 B	P/E(ttm)
Enterprise Value	3.22 B	P/B	32.00

ARIA- NAS (USA)
Ariad Pharmaceuticals

Currently 1/5

Business Predictability Rank: 1-Star
Back Testing Results:
Average gain of all 1-Star stocks: 1.1% per year.
% of Stocks that are in still loss if held for 10yrs: 45%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$19.57

3 Severe Warning Signs 1 Medium Warning Sign 1 Good Sign

Bookmark

To find out why GuruFocus thinks data on insider trade are interesting, please read:

Also See GuruFocus Insider Trade Screener:

Total Records: 118 Page:1 2 3 4 5 6

Insider	Position	Date	Buy/Sell	Shares	Shares Owned Following This	Trade Price ($)	Cost ($1000)	Price Change Since Trade (%)	Details
BERGER HARVEY J M D	Chairman & CEO (Click for the stocks that their CEOs have bought)	2013-05-15	Sell	92,498	3,516,776	$18.1	1674.2	8.12	Link
BERGER HARVEY J M D	Chairman & CEO	2013-04-17	Sell	105,400	3,672,860	$18.01	1898.3	8.66	Link
Bollag Daniel M	Sr. VP, Reg. Affairs & Quality	2013-04-02	Sell	2,400	117,871	$18.05	43.3	8.42	Link
BERSTEIN DAVID L	Senior VP, Chief IP Officer	2013-04-02	Sell	2,400	208,898	$18.05	43.3	8.42	Link
FITZGERALD EDWARD M	Executive VP, CFO	2013-04-02	Sell	5,200	199,355	$18.04	93.8	8.48	Link
DODION PIERRE F	SVP, Corp. Dev. & Operations	2013-04-02	Sell	2,400	57,682	$18.04	43.3	8.48	Link
CLACKSON TIMOTHY P	President, R&D, CSO	2013-04-02	Sell	6,500	363,705	$18.04	117.3	8.48	Link
Cantor Maria E	SVP, Corporate Affairs	2013-04-02	Sell	4,250	62,275	$18.04	76.7	8.48	Link
Haluska Frank	SVP, Clinical R&D, CMO	2013-04-02	Sell	3,400	73,907	$18.04	61.3	8.48	Link
Keane Raymond T	SVP General Counsel & CCO	2013-04-02	Sell	2,583	54,096	$18.05	46.6	8.42	Link
FITZGERALD EDWARD M	Executive VP, CFO	2013-03-26	Sell	12,933	191,555	$18.75	242.5	4.37	Link
Bollag Daniel M	Sr. VP, Reg. Affairs & Quality	2013-03-25	Sell	12,933	114,271	$18.87	244	3.71	Link
CLACKSON TIMOTHY P	President, R&D, CSO	2013-03-25	Sell	19,167	357,205	$18.87	361.7	3.71	Link
Haluska Frank	SVP, Clinical R&D, CMO	2013-03-25	Sell	5,333	68,807	$18.88	100.7	3.65	Link
BERSTEIN DAVID L	Senior VP, Chief IP Officer	2013-03-25	Sell	10,533	205,298	$18.87	198.8	3.71	Link
DODION PIERRE F	SVP, Corp. Dev. & Operations	2013-03-25	Sell	8,133	54,082	$18.87	153.5	3.71	Link
Keane Raymond T	SVP General Counsel & CCO	2013-03-25	Sell	13,167	51,513	$18.87	248.5	3.71	Link
Duvall Martin J	SVP, Commercial Operations	2013-03-22	Sell	576	2,854	$19.53	11.2	0.2	Link
Haluska Frank	SVP, Clinical R&D, CMO	2013-03-22	Sell	2,400	60,807	$19.46	46.7	0.57	Link
DODION PIERRE F	SVP, Corp. Dev. & Operations	2013-03-22	Sell	2,400	41,882	$19.46	46.7	0.57	Link

Total Records: 118 Page:1 2 3 4 5 6

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles